Media Summary: Andrew Spiegel, Executive Director of the Global Cancer Association, discusses how the IRA's Panel discussion Inflation Reduction Act's new Thanks to the 2022 Inflation Reduction Act (IRA), millions of Americans are seeing savings in their annual healthcare

Asbm Gabi Webinar Medicare Drug Price Negotiation Impacts On Innovation And Patient Access - Detailed Analysis & Overview

Andrew Spiegel, Executive Director of the Global Cancer Association, discusses how the IRA's Panel discussion Inflation Reduction Act's new Thanks to the 2022 Inflation Reduction Act (IRA), millions of Americans are seeing savings in their annual healthcare Join moderator Alison Cuellar, PhD, professor and director of the Health Policy Collaboratory, for the 2023 Health Policy Speaker ... In this episode, Todd Askew, AMA senior vice president of Advocacy, presents what physicians need to know about Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back ...

By September 1, CMS is expected to publish its list of the first 10 For people with complex health and social needs who also have complicated Over the past century, pharmaceutical product

Photo Gallery

ASBM/GaBI Webinar- Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access
MEDICARE DRUG PRICE NEGOTIATIONS: impact on healthcare development and patient access to medicines
Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access-Part 3 : Steven Potts
Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access Part 5 Andrew Spiegel
Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access- Part 6 Panel Discussion
Watch Live | Medicare Drug Price Negotiation, How to Ensure Access & Equity
Those who worked on Medicare Part D describe harmful impacts of IRA's Drug Price Negotiation Policy
Medicare Drug Price Negotiation, How to Ensure Access & Equity | WATCH NOW
Medicare’s New Drug Price Negotiation Program: 2023 Health Policy Speaker Series
What to know about Medicare drug price negotiation
ASBM/GaBI 2022 Webinars: KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US
Webinar: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Report
Sponsored
Sponsored
View Detailed Profile
ASBM/GaBI Webinar- Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access

ASBM/GaBI Webinar- Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access

On July 26th,

MEDICARE DRUG PRICE NEGOTIATIONS: impact on healthcare development and patient access to medicines

MEDICARE DRUG PRICE NEGOTIATIONS: impact on healthcare development and patient access to medicines

The Alliance For Safe Biologic

Sponsored
Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access-Part 3 : Steven Potts

Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access-Part 3 : Steven Potts

Cancer

Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access Part 5 Andrew Spiegel

Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access Part 5 Andrew Spiegel

Andrew Spiegel, Executive Director of the Global Cancer Association, discusses how the IRA's

Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access- Part 6 Panel Discussion

Medicare Drug Price Negotiation: Impacts on Innovation and Patient Access- Part 6 Panel Discussion

Panel discussion Inflation Reduction Act's new

Sponsored
Watch Live | Medicare Drug Price Negotiation, How to Ensure Access & Equity

Watch Live | Medicare Drug Price Negotiation, How to Ensure Access & Equity

Thanks to the 2022 Inflation Reduction Act (IRA), millions of Americans are seeing savings in their annual healthcare

Those who worked on Medicare Part D describe harmful impacts of IRA's Drug Price Negotiation Policy

Those who worked on Medicare Part D describe harmful impacts of IRA's Drug Price Negotiation Policy

From

Medicare Drug Price Negotiation, How to Ensure Access & Equity | WATCH NOW

Medicare Drug Price Negotiation, How to Ensure Access & Equity | WATCH NOW

Thanks to the 2022 Inflation Reduction Act (IRA), millions of Americans are seeing savings in their annual healthcare

Medicare’s New Drug Price Negotiation Program: 2023 Health Policy Speaker Series

Medicare’s New Drug Price Negotiation Program: 2023 Health Policy Speaker Series

Join moderator Alison Cuellar, PhD, professor and director of the Health Policy Collaboratory, for the 2023 Health Policy Speaker ...

What to know about Medicare drug price negotiation

What to know about Medicare drug price negotiation

In this episode, Todd Askew, AMA senior vice president of Advocacy, presents what physicians need to know about

ASBM/GaBI 2022 Webinars: KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US

ASBM/GaBI 2022 Webinars: KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US

The Alliance For Safe Biologic

Webinar: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Report

Webinar: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Report

December, 2023.

CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back ...

How Will Medicare Negotiate Drug Prices? What Patients Need to Know

How Will Medicare Negotiate Drug Prices? What Patients Need to Know

Under the Inflation Reduction Act,

8/1/23 - More Than A List: The Ripple Effect of the IRA on Patient Access & Medicare Part D

8/1/23 - More Than A List: The Ripple Effect of the IRA on Patient Access & Medicare Part D

By September 1, CMS is expected to publish its list of the first 10

Negotiating Access and Prices of Pharmaceuticals: It’s Time for a Better Approach

Negotiating Access and Prices of Pharmaceuticals: It’s Time for a Better Approach

How do we

Building the Business Case and Value-Based Payment Models for Enhanced Medication Management

Building the Business Case and Value-Based Payment Models for Enhanced Medication Management

For people with complex health and social needs who also have complicated

The Continued Conundrum of Drug Pricing

The Continued Conundrum of Drug Pricing

Over the past century, pharmaceutical product